by Bianca QuijanoApr 16, 20182 minPembrolizumab reduced recurrence risk of stage 3 melanomaAfter a median follow-up of 15 months, 135 of the 514 patients treated with pembrolizumab and 216 of the 505 patients treated with placebo
by John EvansApr 13, 20182 minMacrophages impair PD-1 immunotherapy in melanoma"Our study suggests that assessing the abundance of macrophages and the contextual presence of CD8 T-cells—for example by measuring gen
by Bianca QuijanoMar 26, 20182 minMelanoma: Obesity may provide a survival advantageResearchers concluded that these findings are an example of the “obesity paradox” in melanoma—the occurrence observed in some types of cance
Derm CityMar 12, 20182 minHighly mutated cancer gene, KMT2D, coordinates skin tissue renewalThe protein KMT2D, a mutated gene involved in skin cancer, is also a key driver in guiding the renewal of epithelial tissues.